Sweden · Biotechnology startup
Sweden · Elypta
Preventing cancer mortality by developing a metabolism-based liquid biopsy platform for early detection and monitoring
Funding reportedLast round: Grant
What company datasets say Elypta raised
Funding, as reported
Reported in all33.6Min the source's currency
Rounds7
Last roundGrant
Last round dateMar 2023
Investors listed11
Founders and team
From Elypta's own website: 1 founder, 20 on the team.
Jens NielsenChairman, Founder
- Karl BergmanCEO
- Johan VikströmChief Financial Officer
- Volker LiebenbergChief Medical Officer
- Andrea BomanVP Quality & Regulatory
- Gabriel OrtizVP of Software Engineering
- Karin MattssonVP of Research & Development
- Anna AngelopoulouSenior Research Engineer
- Davide TamburroPrincipal Research Scientist
- Elin AlmstedtBoard Member
- Eva PisaBoard Member
- Flavia PlastinoResearch Scientist
- Hannah ThielSenior Research Engineer
- Hilja IbertBoard Member
- Jonas JendiBoard Member
- Laimei LundströmSenior Data Scientist
- Liudmyla KorshunProduction Manager
- Marianna MirabelliDirector of Clinical Development
- Rena SiopiSenior Research Scientist
And 2 more on the team.
AdvisersFrancesco Gatto
On 2 portfolio pages
Investors who name them
Each firm lists Elypta on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.
Biotechnology in Sweden
Startups like it
Is this your company?
Add your raise, your deck and your story, and put Elypta in front of investors. Or tell us what we have wrong.